Decentralisation of multidrug-resistant-tuberculosis care and management

The Lancet Infectious Diseases

Volumn 13, Issue 8, 2013, Pages 644-646

  Cox, Helen ^a,b   Ford, Nathan ^b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

AMBULATORY CARE; FUNDING; HEALTH CARE DELIVERY; HUMAN; LETTER; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; PATIENT CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUBERCULOSIS CONTROL;

ANTITUBERCULAR AGENTS; DELIVERY OF HEALTH CARE; HUMANS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84880699783     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70151-8     Document Type: Letter

References (14)

1. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010, 363:1005-1015.
2. Voelker R MDR-TB has new drug foe after fast-track approval. JAMA 2013, 309:430.
3. Falzon D, Jaramillo E, Wares F, Zignol M, Floyd K, Raviglione MC Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data. Lancet Infect Dis 2013, published online June 4. http://dx.doi.org/10.1016/S1473-3099(13)70130-0.
4. Fitzpatrick C, Floyd K A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis. Pharmacoeconomics 2012, 30:63-80.
5. Nathanson E, Lambregts-van Weezenbeek C, Rich ML, et al. Multidrug-resistant tuberculosis management in resource-limited settings. Emerg Infect Dis 2006, 12:1389-1397.
6. Toczek A, Cox H, du Cros P, Cooke G, Ford N Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2013, 17:299-307.
7. Shin S, Furin J, Bayona J, Mate K, Kim JY, Farmer P Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Soc Sci Med 2004, 59:1529-1539.
8. Brust JC, Shah NS, Scott M, Chaiyachati K, et al. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care. Int J Tuberc Lung Dis 2012, 16:998-1004.
9. Malla P, Kanitz EE, Akhtar M, et al. Ambulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006. PLoS One 2009, 4:e8313.
10. Scaling up diagnosis and treatment of drug-resistant tuberculosis in Khayelitsha, South Africa 2011, Medecins Sans Frontieres, Medecins Sans Frontieres, Cape Town, (accessed May 23, 2013). http://www.msf.org.za/publication/scaling-diagnosis-and-treatment-drug-resistant-tuberculosis-khayelitsha-south-africa.
11. Farley LDJ, Mlandu N, Ndjeka N, Richard P, ven der Walt M. Nurse initiation and management of MDR-TB-HIV: lessons from operational research. 43rd Union conference on lung health; Kuala Lumpur; Nov 13-17, 2012.
12. Fatti G, Grimwood A, Bock P Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces. PLoS One 2010, 5:e12888.
13. Fayorsey RN, Saito S, Carter RJ, et al. Decentralization of pediatric HIV care and treatment in five sub-Saharan African countries. J Acquir Immune Defic Syndr 2013, 62:e124-e130.
14. Nardell E, Dharmadhikari A Turning off the spigot: reducing drug-resistant tuberculosis transmission in resource-limited settings. Int J Tuberc Lung Dis 2010, 14:1233-1243.